Antimicrobial peptides in skin diseases
AuthorPinkey, Monika Tabassum
MetadataShow full item record
Skin diseases, including inflammatory and infections, result from disruptions in the skin's barrier. Antimicrobial peptides (AMPs) have recently gained attention as potential treatments for inflammatory, soft skin tissue and wound infections. This review discusses AMPs in skin diseases. It highlights the therapeutic properties of AMPs and their potential utility in treating skin disorders. Even though only a few AMPs, such as oritavancin and daptomycin, have been approved for use in clinical trials. Moreover, omiganan, pexiganan, and DPK-060 have also been studied extensively for treating skin problems. This paper also mentions some strategies to increase AMPs' clinical trial success rate.